Longitude Capital
  • ABOUT
  • TEAM
  • PORTFOLIO
  • NEWS
  • CONTACT
  • LP LOGIN
Select Page

Collegium Pharmaceutical Releases Positive Top-Line Results of Oral Human Abuse Potential (HAP) Study with Oxycodone DETERx®, an Abuse-Deterrent, Extended-Release Product

by longitudeadmin | Nov 17, 2014 | Portfolio News

Collegium: Emerging Player in Abuse-Deterrent Opioids

by longitudeadmin | Nov 3, 2014 | Portfolio News

Practice Fusion Launches Brand New Electronic Health Records (EHR) Platform, Optimized for Apple iPad™, iPad mini™ and Android™ Tablets

by longitudeadmin | Oct 27, 2014 | Portfolio News

Esperion Therapeutics Announces Closing of Follow-On Public Offering and Exercise in Full of Underwriters’ Option to Purchase Additional Shares of Common Stock

by longitudeadmin | Oct 21, 2014 | Portfolio News

Esperion Therapeutics Announces Positive Top-Line Phase 2b Results for ETC-1002, An Investigational Therapy for Patients with Hypercholesterolemia

by longitudeadmin | Oct 1, 2014 | Portfolio News

« Older Entries

Media Contact

Maggie Jamison

mjamison@longitudecapital.com

650-854-5700

  • Facebook
  • Twitter
  • Google
  • RSS
footer-logo

LP Login

© 2023 Longitude Capital. All rights reserved.
  • Privacy Policy
  • Disclaimer